Clearstead Trust LLC Has $2.23 Million Stock Position in The Procter & Gamble Company (NYSE:PG)

Clearstead Trust LLC trimmed its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 4.4% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 13,537 shares of the company’s stock after selling 627 shares during the period. Clearstead Trust LLC’s holdings in Procter & Gamble were worth $2,233,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Tower Wealth Partners Inc. boosted its stake in shares of Procter & Gamble by 1.0% during the 2nd quarter. Tower Wealth Partners Inc. now owns 11,809 shares of the company’s stock worth $1,948,000 after acquiring an additional 121 shares in the last quarter. Peregrine Asset Advisers Inc. lifted its position in shares of Procter & Gamble by 630.9% in the 2nd quarter. Peregrine Asset Advisers Inc. now owns 41,267 shares of the company’s stock worth $6,806,000 after acquiring an additional 35,621 shares during the period. Capstone Wealth Management Group LLC lifted its position in shares of Procter & Gamble by 5.5% in the 2nd quarter. Capstone Wealth Management Group LLC now owns 10,514 shares of the company’s stock worth $1,734,000 after acquiring an additional 551 shares during the period. Edgestream Partners L.P. bought a new stake in shares of Procter & Gamble in the 2nd quarter worth approximately $5,213,000. Finally, Moors & Cabot Inc. raised its holdings in shares of Procter & Gamble by 0.3% in the 2nd quarter. Moors & Cabot Inc. now owns 145,510 shares of the company’s stock worth $23,997,000 after buying an additional 453 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Jon R. Moeller sold 72,174 shares of the company’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the completion of the transaction, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at $45,002,649.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the sale, the chief executive officer now owns 263,537 shares in the company, valued at $44,508,763.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Jon R. Moeller sold 72,174 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the sale, the chief executive officer now owns 263,158 shares in the company, valued at approximately $45,002,649.58. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 375,553 shares of company stock valued at $63,829,141. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Stock Up 1.8 %

NYSE:PG opened at $177.25 on Tuesday. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $177.94. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $418.33 billion, a P/E ratio of 28.96, a P/E/G ratio of 3.76 and a beta of 0.41. The stock’s fifty day simple moving average is $169.59 and its 200-day simple moving average is $165.37.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $20.53 billion during the quarter, compared to analysts’ expectations of $20.69 billion. During the same period in the previous year, the firm earned $1.37 earnings per share. The company’s revenue was down .1% on a year-over-year basis. Equities research analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a $1.0065 dividend. The ex-dividend date was Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a yield of 2.27%. Procter & Gamble’s payout ratio is 65.85%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on PG shares. Deutsche Bank Aktiengesellschaft raised their price target on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. JPMorgan Chase & Co. dropped their price target on Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating for the company in a report on Wednesday, July 31st. Stifel Nicolaus raised their price target on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a report on Monday, July 22nd. TD Cowen started coverage on Procter & Gamble in a report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target for the company. Finally, Barclays dropped their price target on Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a report on Thursday, August 1st. Seven investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus target price of $175.79.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.